{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:54:11Z","timestamp":1787496851905,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Radiation therapy is a widely used treatment for cancer, but it can have detrimental effects on the heart, leading to radiotherapy-induced cardiotoxicity. This condition has become an area of increasing concern, especially as cancer treatments continue to evolve. This review aims to explore the recent literature on radiotherapy-induced cardiotoxicity, focusing on the latest research published. The goal is to identify recent advances in understandings of the underlying mechanisms of damage, risk factors, screening modalities, risk stratification, and novel treatment strategies for mitigating radiotherapy-induced cardiotoxicity. A narrative literature review of PubMed articles from the last 3 years was conducted to gather recent research on radiotherapy-induced cardiotoxicity including keywords such as \u201ccardiac complications,\u201d \u201ccardiotoxicity,\u201d \u201cradiotherapy,\u201d and \u201cradiation.\u201d This review identifies advances in understanding the mechanisms of cardiac damage, particularly the roles of humoral immunity and endothelial dysfunction. Recent studies have also highlighted key risk factors, including radiation dose, genetic predispositions, underlying cardiovascular conditions, and lifestyle factors. Additionally, the review emphasizes the need for enhanced surveillance and early detection of cardiotoxicity following radiation therapy, proposing a combined approach involving both imaging techniques and biomarker monitoring for more accurate assessment. Novel imaging methods and emerging biomarkers are being explored for their potential in improving detection and risk stratification. This review article also outlines the national guidelines and clinical recommendations for the prevention and management of radiotherapy-related cardiotoxicity. Despite these advancements, there remain significant gaps in understanding the full range of factors contributing to radiotherapy-induced cardiotoxicity, including the genetic contribution and the interaction between radiotherapy and other cancer treatments with regard to their contributions to cardiotoxicity. Additionally, further research is indicated to further elucidate the mechanisms of damage and the significance of biomarker changes relating to cardiotoxicity. Overall, this review underscores the importance of ongoing research to mitigate the cardiovascular risks associated with radiotherapy.<\/jats:p>","DOI":"10.1097\/crd.0000000000000894","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T09:02:57Z","timestamp":1741251777000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Cardiac Complications of Radiation Therapy: A Narrative Review of Recent Literature"],"prefix":"10.1097","author":[{"given":"Elisheva","family":"Eisenberg","sequence":"first","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Depatment of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"},{"name":"Depatment of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"R1-20250306","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/bs.acr.2022.03.006","article-title":"Cardiac complications of cancer therapies.","volume":"155","author":"Mauro","year":"2022","journal-title":"Adv Cancer Res"},{"key":"R2-20250306","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11886-022-01834-x","article-title":"Recent advances in serum biomarkers for risk stratification and patient management in cardio-oncology.","volume":"25","author":"Joolharzadeh","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"R3-20250306","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1200\/JCO.22.02320","article-title":"Cardiac substructure radiation dose and risk of late cardiac disease in survivors of childhood cancer: a report from the childhood cancer survivor study.","volume":"41","author":"Bates","year":"2023","journal-title":"J Clin Oncol"},{"key":"R4-20250306","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cam4.4948","article-title":"Dual effect of radiotherapy related concomitant cardiovascular diseases in non-small cell lung cancer.","volume":"12","author":"Mo","year":"2023","journal-title":"Cancer Med"},{"key":"R5-20250306","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/09553002.2021.1956007","article-title":"The cardiac toxicity of radiotherapy\u2014a review of characteristics, mechanisms, diagnosis, and prevention.","volume":"97","author":"Wei","year":"2021","journal-title":"Int J Radiat Biol"},{"key":"R6-20250306","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/ehf2.13365","article-title":"Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications.","volume":"8","author":"Bikiewicz","year":"2021","journal-title":"ESC Heart Fail"},{"key":"R7-20250306","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10585-021-10106-x","article-title":"Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship.","volume":"38","author":"de Wall","year":"2021","journal-title":"Clin Exp Metastasis"},{"issue":"Suppl 2","key":"R8-20250306","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.2967\/jnumed.122.264868","article-title":"Molecular imaging biomarkers in cardiooncology: a view on established technologies and future perspectives.","volume":"64","author":"Kersting","year":"2023","journal-title":"J Nucl Med"},{"key":"R9-20250306","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1200\/JCO.21.01736","article-title":"Risk of cardiovascular disease in women with and without breast cancer: the pathways heart study.","volume":"40","author":"Greenlee","year":"2022","journal-title":"J Clin Oncol"},{"key":"R10-20250306","doi-asserted-by":"crossref","first-page":"107751","DOI":"10.1016\/j.pharmthera.2020.107751","article-title":"Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence.","volume":"221","author":"Abdelgawad","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R11-20250306","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/10998004221098113","article-title":"Inflammatory, oxidative stress, and cardiac damage biomarkers and radiation-induced fatigue in breast cancer survivors.","volume":"24","author":"Vasbinder","year":"2022","journal-title":"Biol Res Nurs"},{"key":"R12-20250306","doi-asserted-by":"crossref","first-page":"106235","DOI":"10.1016\/j.envint.2020.106235","article-title":"Ionizing radiation-induced circulatory and metabolic diseases.","volume":"146","author":"Tapio","year":"2021","journal-title":"Environ Int"},{"key":"R13-20250306","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2326-6066.CIR-21-0839","article-title":"Autoantibodies drive heart damage caused by concomitant radiation and PD-1 blockade.","volume":"11","author":"Yan","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"R14-20250306","doi-asserted-by":"crossref","first-page":"108116","DOI":"10.1016\/j.pharmthera.2022.108116","article-title":"Endothelial dysfunction as a complication of anti-cancer therapy.","volume":"237","author":"Terwoord","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R15-20250306","doi-asserted-by":"crossref","first-page":"e072924","DOI":"10.1136\/bmj-2022-072924","article-title":"Ionising radiation and cardiovascular disease: systematic review and meta-analysis.","volume":"380","author":"Little","year":"2023","journal-title":"BMJ"},{"key":"R16-20250306","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijrobp.2020.12.053","article-title":"Risk of cardiac disease in patients with breast cancer: impact of patient-specific factors and individual heart dose from three-dimensional radiation therapy planning.","volume":"110","author":"Chung","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-20250306","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2021.08.017","article-title":"Coronary artery calcifications and cardiac risk after radiation therapy for stage III lung cancer.","volume":"112","author":"Wang","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20250306","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/hematology.2022000342","article-title":"Mitigating, monitoring, and managing long-term chemotherapy- and radiation-induced cardiac toxicity.","volume":"2022","author":"Bottinor","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R19-20250306","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/joim.13547","article-title":"Pediatric obesity\u2014long-term consequences and effect of weight loss.","volume":"292","author":"Marcus","year":"2022","journal-title":"J Intern Med"},{"key":"R20-20250306","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaoncol.2018.2254","article-title":"Association of exercise with mortality in adult survivors of childhood cancer.","volume":"4","author":"Scott","year":"2018","journal-title":"JAMA Oncol"},{"key":"R21-20250306","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2022.03.010","article-title":"Genetics of cancer therapy-associated cardiotoxicity.","volume":"167","author":"Kim","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"R22-20250306","doi-asserted-by":"crossref","first-page":"e2347449","DOI":"10.1001\/jamanetworkopen.2023.47449","article-title":"Primary care utilization and cardiovascular screening in adult survivors of childhood cancer.","volume":"6","author":"Ohlsen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R24-20250306","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cncr.33292","article-title":"Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort.","volume":"127","author":"Dixon","year":"2021","journal-title":"Cancer"},{"key":"R25-20250306","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jtho.2022.10.017","article-title":"The interaction of preexisting cardiac dysfunction and heart dose from radical radiotherapy on all-cause mortality in locally advanced NSCLC.","volume":"18","author":"Colori","year":"2023","journal-title":"J Thorac Oncol"},{"key":"R26-20250306","doi-asserted-by":"crossref","first-page":"e20220809","DOI":"10.1084\/jem.20220809","article-title":"Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies.","volume":"220","author":"Shamseddine","year":"2023","journal-title":"J Exp Med"},{"key":"R27-20250306","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1200\/JCO.2016.70.5400","article-title":"Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of clinical oncology clinical practice guideline.","volume":"35","author":"Armenian","year":"2017","journal-title":"J Clin Oncol"},{"key":"R28-20250306","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.jtho.2024.09.1433","article-title":"American Radium Society appropriate use criteria on cardiac toxicity prevention and management after thoracic radiotherapy.","volume":"19","author":"Amini","year":"2024","journal-title":"J Thorac Oncol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T09:03:05Z","timestamp":1741251785000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000894","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}